It has been demonstrated that enhanced de novo lipogenesis in the liver, a process consisting of conversion of acetyl-coenzyme A to free fatty acids, is crucial for NAFLD development and can down regulate SHBG synthesis (44, 45). Here, SHBG is linked to metabolic dysfunction-associated steatotic liver disease.